SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
journal of medical economics
j med econ
ISSN 1941-837X
418 views
Indexed In
ncbi
ulakbim
sci
Publications
10
ULAKBİM
MEP: NULL
Ödeme: 3750
Yılı: 2020
Details
Abbreviated Name
j med econ
ISSN
1941-837X
Publications/Year
Top Clicked Bibliographies from Search
1
Clinical and economic benefits associated with the use of powered and tissue-specific endoscopic staplers among the patients undergoing thoracoscopic lobectomy for lung cancer.
2019
380 clicks
5
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK.
2019
284 clicks
3
Correction to: Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations (Journal of Medical Economics, (2018), (1-8), 10.1080/13696998.2018.1542520)
2019
282 clicks
8
Healthcare resource utilization and direct medical costs associated with index and recurrent infection: A real-world data analysis.
2020
266 clicks
4
The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States.
2018
265 clicks
6
Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
2020
256 clicks
2
Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.
2019
245 clicks
10
Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models.
2020
243 clicks
7
Health technology assessment in Japan: a work in progress.
2020
242 clicks
9
Cost effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China.
2020
236 clicks